Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. LAB
LAB logo

LAB Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Standard BioTools Inc (LAB) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
1.150
1 Day change
0.88%
52 Week Range
1.720
Analysis Updated At
2026/05/29
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

LAB is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The technical setup is mildly constructive, but there is no proprietary buy signal, no recent news catalyst, no analyst upgrade momentum, and no financial snapshot to support a confident long-term purchase. If the investor is unwilling to wait for an optimal entry, this is still not compelling enough to buy aggressively at the current pre-market price of 1.14. My direct view: hold and wait for clearer confirmation.

Technical Analysis

LAB is showing short-term positive momentum, but the signal is not strong enough to call it a buy. MACD histogram is positive at 0.0125 and expanding, which supports near-term upside. However, RSI_6 is 75.73, which indicates the stock is extended rather than attractively valued for entry. Moving averages are converging, suggesting the trend is still forming and not yet decisive. Price is currently near resistance at 1.122 and below R2 at 1.164, while pivot support sits at 1.053 and S1 at 0.985. Overall trend: mildly bullish short term, but not an ideal long-term entry.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options sentiment is bullish. The put-call ratios are low, with open interest put-call ratio at 0.29 and option volume put-call ratio at 0.46, indicating more call activity than put activity. Implied volatility is 64.19, above the 5d and 10d averages, while IV rank is low at 6.4 and IV percentile is 14.68, suggesting volatility is not excessively stretched versus history. Option flow leans positive, but the absolute trading activity is still modest, so this is a supportive but not decisive signal.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
6
Buy
7

Positive Catalysts

  • ["Bullish options sentiment with low put-call ratios", "MACD histogram is positive and expanding", "Price is above the main pivot level", "Similar candlestick pattern stats imply upside potential over the next week and month"]

Neutral/Negative Catalysts

  • ["No news in the recent week", "No recent AI Stock Picker signal", "No recent SwingMax signal", "No meaningful hedge fund accumulation trend", "No significant insider buying trend", "No recent congress trading data", "Financial snapshot unavailable, so latest quarter growth cannot be verified", "RSI is elevated, suggesting the stock may be short-term extended"]

Financial Performance

Financial data was not available due to an error in the snapshot, so the latest quarter season and growth trends cannot be assessed. Because the company’s recent quarterly performance is missing, there is no basis here to argue for a confident long-term buy from fundamentals.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target trend data was provided, so there is no visible evidence of a bullish revision cycle. Wall Street appears neutral by default based on the lack of upgrades, price target raises, or strong coverage momentum.

Wall Street analysts forecast LAB stock price to rise
2 Analyst Rating
Wall Street analysts forecast LAB stock price to rise
0 Buy
2 Hold
0 Sell
Hold
Current: 1.140
sliders
Low
1.35
Averages
1.35
High
1.35
Current: 1.140
sliders
Low
1.35
Averages
1.35
High
1.35
TD Cowen
Hold
downgrade
AI Analysis
2025-11-05
Reason
TD Cowen
Price Target
AI Analysis
2025-11-05
downgrade
Hold
Reason
TD Cowen lowered the firm's price target on Standard BioTools to $1.35 from $1.55 and keeps a Hold rating on the shares. The firm said there were no surprises in the print with the company now reporting continuing operations revenue post the announced sale of SomaLogic.
TD Cowen
Buy
to
Hold
downgrade
2025-08-13
Reason
TD Cowen
Price Target
2025-08-13
downgrade
Buy
to
Hold
Reason
TD Cowen downgraded Standard BioTools to Hold from Buy with a price target of $1.55, down from $1.60, post the Q2 report. The company sees a lower growth outlook for the core business and less visibility following the sale of SomaLogic. The company's core business trends will continue to be challenged amid macro headwinds, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for LAB
Unlock Now

People Also Watch